Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis patients with an APACHE II score of 25 or greater at baseline: results from ENHANCE

פריטים דומים

• Eligibility for drotrecogin alfa therapy on the basis of APACHE II score and organ failure
  מאת: Shulman, R, et al.
  יצא לאור: (2005)
• The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
  מאת: Vincent, J, et al.
  יצא לאור: (2004)
• Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis patients with two or more organ dysfunctions at baseline: results from ENHANCE
  מאת: Vincent, J, et al.
  יצא לאור: (2004)
• Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
  מאת: Beale, R, et al.
  יצא לאור: (2007)
• Neuroaxial catheters following abdominal surgery and their impact on the use of Drotrecogin alfa (activated) in sepsis
  מאת: Steel, A, et al.
  יצא לאור: (2004)